Conference

Kenneth Getz, MBA, Executive Director & Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

9:00AM - 9:30AM

AI Keynote - What CMOs Need To Know About AI and its Role in Drug Development

Dina Katabi, PhD, Thuan and Nicole Pham Professor of Electrical Engineering and Computer Science, MIT

Showing Events in 1 Track from 09:30am to 10:15am

Morning Break & Networking

9:30AM - 10:15AM

Morning Break & Networking

Showing Events in 1 Track from 10:15am to 12:30pm

Day 2 Morning General Session Continued

10:15AM - 10:45AM

What AI is Doing for the CMO Clinical Development Toolbox

Steve Zelenkofske, DO, President/Principal, SLZ Consulting

Panelist:

Leonardo Faoro, MD, MBA, CMO, Quanta Therapeutics

Gen Li, PhD, MBA, President and Founder, Phesi, Inc.

10:45AM - 11:00AM

AI/ML in Clinical Development: Population Enrichment, Risk and Response Prediction

Natasha Mühlemann, MD, MBA, Vice President, Strategic Consulting, Cytel

11:00AM - 11:30AM

What Investors Are Looking For in 2024

Alex Snyder, MD, EVP, Research and Development, Generate Biomedicines

Laurent Audoly, PhD, Executive Partner, Apollo Health Ventures

Jakob Dupont, MD, Executive Partner, Sofinnova Investments, Inc.

Albert Kim, MD, PhD, Venture Partner, RA Ventures

Yaping Shou, MD, PhD, Venture Partner, Lilly Asia Ventures

11:30AM - 12:00PM

CMO Insights and Advice on Tailoring Your Pitch to Investors

Howard Rutman, MD, MBA, CMO, Xalud Therapeutics

Robert Brown, MD, CMO, Oncology, Zai Laboratory

Daniel Chung, DO, MA, CMO, SparingVision

Scott Harris, MD, CMO, Altimmune

12:00PM - 12:30PM

Best Practices Throughout the Lifecycle of Pharma-Biotech Partnerships and M&A

Seemi Khan, MD, MPH, MBA, CMO, Alkeus Pharmaceuticals

Joseph Palumbo, MD, MACPsych, EVP, CMO, Head of Research & Development, BioVie

Tadaaki Taniguchi, MD, PhD, CMO, Astellas Pharma

Showing Events in 1 Track from 12:30pm to 01:30pm

Lunch

12:30PM - 1:30PM

Lunch and Roundtable Choices

Showing Events in 7 Tracks from 12:50pm to 01:25pm

Roundtable 1: Cell & Gene Therapy

Cell & Gene Therapy

Marcus Conant, MD, CMO, American Gene Technologies

Andrew Dietz, MD, VP, Head of Clinical Research & Development and Regulatory Affairs, Shape Therapeutics, Inc.

Roundtable 2: Oncology

Oncology

Christopher Turner, MD, CMO, Nuvalent

Roundtable 3: CNS

CNS

Aaron Koenig, MD, CMO, Delix Therapeutics

Robert Lasser, MD, MBA, CMO, Noema Pharma Inc

Roundtable 4: Rare Disease

Rare Disease

Danko Dominis, MD, PhD, VP, Global Medical Officer, Biotech Solutions, PPD, part of Thermo Fisher Scientific

Alison Schecter, MD, CEO, Molecules to Medicine (MTM) Advisory Group

Roundtable 5: Inflammation & Immunology

Inflammation & Immunology

Neely Mozaffarian, MD, PhD, CMO, Atomwise

Uptal Patel, MD, CMO, HI-Bio

Roundtable 6: Getting Your First Board Seat and What to Expect

Getting Your First Board Seat and What to Expect

Sophia Davis, Founder, BioDirectors, LLC

Roundtable 7: Make an Impact through Storytelling

Make an Impact through Storytelling

Donna Schwarz, Executive & Communications Coach, Schwarz Consultants

Showing Events in 1 Track from 01:30pm to 04:00pm

Day 2 Evening General Session

1:30PM - 2:00PM

Best Practices Interacting with Boards throughout the Biotech Lifecycle

Barbara Wirostko, MD, CMO & Co-Founder, Qlaris Bio

Randall Kaye, MD, MPH, CMO, Longboard Pharmaceuticals

Yan Moore, MD, MBA, CMO, Omega Therapeutics

2:00PM - 2:30PM

Learning & Unlearning to Succeed as a CMO

Marcella Ruddy, MD, CMO, Tectonic Therapeutic

Mark Bach, MD, PhD, CMO, Structure Therapeutics

Jeremy Sokolove, MD, CMO, Odyssey Therapeutics

Norman Sussman, MD, CMO, DURECT

2:30PM - 3:00PM

Gathering Expertise in New Indications and Modalities

Mustafa Noor, MD, CMO, Olatec Therapeutics

John Goldberg, MD, CMO, Rafael Holdings

Kari Varkila, MD, PhD, MBA, CMO, TILT Biotherapeutics / Linio Biotech

3:00PM - 3:30PM

Career Paths for CMOs

Speakers:

Jeffrey Humphrey, MD, Founder, CEO, Charged Biotherapeutics

Cliff Miras, Managing Partner, Miras Search Partners

Ravi Rao, MD, BChir, PhD, CMO, Sitryx

3:30PM - 4:00PM

Conference Concludes

Showing Events in 1 Track from 08:00am to 08:50am

Morning General Session

8:00AM - 8:50AM

Registration Opens

8:20AM - 8:30AM

Co-Chairs Opening Remarks

Co-Chairs:

Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals

Nerissa Kreher, MD, MBA, Consultant CMO/Board Member, Rezolute Bio

Ed Tucker, MD, MBA, CMO, Jasper Therapeutics

Showing Events in 1 Track from 08:30am to 09:30am

Keynotes

8:30AM - 9:00AM

Annual Keynote Address: Weighing the Feasibility and Impact of Protocol Simplification vs Optimization

Kenneth Getz, MBA, Executive Director & Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

9:00AM - 9:30AM

AI Keynote - What CMOs Need To Know About AI and its Role in Drug Development

Dina Katabi, PhD, Thuan and Nicole Pham Professor of Electrical Engineering and Computer Science, MIT

Showing Events in 1 Track from 09:30am to 10:15am

Morning Break & Networking

9:30AM - 10:15AM

Morning Break & Networking

Showing Events in 1 Track from 10:15am to 12:30pm

Day 2 Morning General Session Continued

10:15AM - 10:45AM

What AI is Doing for the CMO Clinical Development Toolbox

Steve Zelenkofske, DO, President/Principal, SLZ Consulting

Panelist:

Leonardo Faoro, MD, MBA, CMO, Quanta Therapeutics

Gen Li, PhD, MBA, President and Founder, Phesi, Inc.

10:45AM - 11:00AM

AI/ML in Clinical Development: Population Enrichment, Risk and Response Prediction

Natasha Mühlemann, MD, MBA, Vice President, Strategic Consulting, Cytel

11:00AM - 11:30AM

What Investors Are Looking For in 2024

Alex Snyder, MD, EVP, Research and Development, Generate Biomedicines

Laurent Audoly, PhD, Executive Partner, Apollo Health Ventures

Jakob Dupont, MD, Executive Partner, Sofinnova Investments, Inc.

Albert Kim, MD, PhD, Venture Partner, RA Ventures

Yaping Shou, MD, PhD, Venture Partner, Lilly Asia Ventures

11:30AM - 12:00PM

CMO Insights and Advice on Tailoring Your Pitch to Investors

Howard Rutman, MD, MBA, CMO, Xalud Therapeutics

Robert Brown, MD, CMO, Oncology, Zai Laboratory

Daniel Chung, DO, MA, CMO, SparingVision

Scott Harris, MD, CMO, Altimmune

12:00PM - 12:30PM

Best Practices Throughout the Lifecycle of Pharma-Biotech Partnerships and M&A

Seemi Khan, MD, MPH, MBA, CMO, Alkeus Pharmaceuticals

Joseph Palumbo, MD, MACPsych, EVP, CMO, Head of Research & Development, BioVie

Tadaaki Taniguchi, MD, PhD, CMO, Astellas Pharma

Showing Events in 1 Track from 12:30pm to 01:30pm

Lunch

12:30PM - 1:30PM

Lunch and Roundtable Choices

Showing Events in 7 Tracks from 12:50pm to 01:25pm

Roundtable 1: Cell & Gene Therapy

Cell & Gene Therapy

Marcus Conant, MD, CMO, American Gene Technologies

Andrew Dietz, MD, VP, Head of Clinical Research & Development and Regulatory Affairs, Shape Therapeutics, Inc.

Roundtable 2: Oncology

Oncology

Christopher Turner, MD, CMO, Nuvalent

Roundtable 3: CNS

CNS

Aaron Koenig, MD, CMO, Delix Therapeutics

Robert Lasser, MD, MBA, CMO, Noema Pharma Inc

Roundtable 4: Rare Disease

Rare Disease

Danko Dominis, MD, PhD, VP, Global Medical Officer, Biotech Solutions, PPD, part of Thermo Fisher Scientific

Alison Schecter, MD, CEO, Molecules to Medicine (MTM) Advisory Group

Roundtable 5: Inflammation & Immunology

Inflammation & Immunology

Neely Mozaffarian, MD, PhD, CMO, Atomwise

Uptal Patel, MD, CMO, HI-Bio

Roundtable 6: Getting Your First Board Seat and What to Expect

Getting Your First Board Seat and What to Expect

Sophia Davis, Founder, BioDirectors, LLC

Roundtable 7: Make an Impact through Storytelling

Make an Impact through Storytelling

Donna Schwarz, Executive & Communications Coach, Schwarz Consultants

Showing Events in 1 Track from 01:30pm to 04:00pm

Day 2 Evening General Session

1:30PM - 2:00PM

Best Practices Interacting with Boards throughout the Biotech Lifecycle

Barbara Wirostko, MD, CMO & Co-Founder, Qlaris Bio

Randall Kaye, MD, MPH, CMO, Longboard Pharmaceuticals

Yan Moore, MD, MBA, CMO, Omega Therapeutics

2:00PM - 2:30PM

Learning & Unlearning to Succeed as a CMO

Marcella Ruddy, MD, CMO, Tectonic Therapeutic

Mark Bach, MD, PhD, CMO, Structure Therapeutics

Jeremy Sokolove, MD, CMO, Odyssey Therapeutics

Norman Sussman, MD, CMO, DURECT

2:30PM - 3:00PM

Gathering Expertise in New Indications and Modalities

Mustafa Noor, MD, CMO, Olatec Therapeutics